Despite a stock price increase, the company's financial indicators are worrisome. Low ROE, flat earnings growth, and a high payout ratio suggest minimal earnings growth. The company's performance disappoints due to low ROE and lack of reinvestment, resulting in poor earnings growth.

Liaoning Chengda Biotechnology Co., Ltd.'s low P/E ratio stems from declining earnings, potentially leading to further limits on stock price. Negative earnings trend indicates P/E might not have reached its lowest, pointing to possible further decrease in stock price.